Xencor Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Hello, everyone. Thanks for joining us. My name is Jonathan Chang. I'm part of the SVB Leerink equity research team. It's my pleasure to host the management team of Xencor, and we have with us today, President and CEO, Bassil Dahiyat. And for the investors joining us, feel free to submit questions or e-mail them to me at [email protected]. And with that, let's get started.
Bassil, would you please briefly introduce the company?
Sure, and thanks very much, Jonathan, for the opportunity to participate in the Leerink conference today.
Xencor is a protein engineering company. We engineer antibodies and other protein molecules to optimize their functions, often immunologic functions, to make them into drugs. We've built a platform based on this protein engineering approach that's centered on a suite of engineered modules, Fc domains, that are the bottom
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |